This inventor holds 37 USPTO granted patents and 14 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Amira Pharmaceuticals, Inc., Panmira Pharmaceuticals, LLC, Novira Therapeutics, Inc.. Active years: 2008-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, CA (US) (2008 - 2017)
- Encinitas, CA (US) (2015 - 2023)
Company Filing History:
11 out of 23 
11 out of 23 
6 out of 44 
Years Active: 2008-2023
Areas of Expertise:
Title: Nicholas Simon Stock: Innovator in Oncology and Virology
Introduction
Nicholas Simon Stock, based in San Diego, CA, is an accomplished inventor with a remarkable portfolio comprising 37 patents. His work primarily revolves around innovative compounds that hold significant promise in the treatment of various types of cancer and viral infections.
Latest Patents
Among his latest innovations are two noteworthy patents. The first is centered on Triazolone compounds and their uses, specifically designed for treating prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma, and other cancers. This invention not only encompasses compounds of Formula I and their pharmaceutically acceptable salts but also pharmaceutical compositions containing these compounds, aimed at delivering therapeutically effective treatments. Additionally, methods of treatment using selective PPARα antagonists are highlighted, expanding the therapeutic applications to include specific viral infections such as HCV and HIV.
The second patent focuses on sulfide alkyl compounds effective for treating HBV infections. This invention outlines a method to inhibit, suppress, or prevent HBV infection in individuals through the administration of a therapeutically effective amount of these compounds, showcasing Stock’s dedication to advancing medical science in both oncology and virology.
Career Highlights
Nicholas Stock has had a notable career path, contributing to significant advancements in pharmaceutical research. He has garnered experience at prestigious companies such as Amira Pharmaceuticals, Inc. and Panmira Pharmaceuticals, LLC. His deep understanding of chemical compounds has paved the way for transformative treatment options in healthcare.
Collaborations
Collaboration has been a cornerstone in Stock’s journey as an innovator. He has worked alongside prominent coworkers, including John Howard Hutchinson and Brian Andrew Stearns. These collaborations have fostered innovative approaches to ongoing challenges in medical science, leading to the development of his impactful inventions.
Conclusion
With a robust portfolio of patents and a dedicated career in pharmaceutical innovations, Nicholas Simon Stock exemplifies the spirit of invention. His contributions towards effective treatments for cancer and viral infections underscore his importance in the field of medical research, promising a brighter future for patients needing effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile